Flexsteel (FLXS) director awarded 544-share quarterly stock grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
FLEXSTEEL INDUSTRIES INC director receives stock grant as compensation
Director Michael Scott Culbreth acquired 544 shares of Flexsteel common stock on March 12, 2026 through a grant awarded as part of quarterly non-executive director compensation. The shares were recorded at a price of $0.00 per share, indicating a non-cash award. Following this grant, Culbreth directly holds a total of 13,689.023 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Culbreth Michael Scott
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 544 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 13,689.023 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did FLEXSTEEL INDUSTRIES INC (FLXS) report for Michael Scott Culbreth?
Flexsteel reported that director Michael Scott Culbreth received a grant of 544 shares of common stock. The award was part of his quarterly non-executive director compensation and was not an open-market purchase or sale.
Was the FLEXSTEEL INDUSTRIES INC (FLXS) Form 4 transaction a stock purchase or compensation grant?
The Form 4 transaction was a compensation grant, not a stock purchase. Michael Scott Culbreth received 544 shares of common stock as part of his quarterly non-executive director compensation package at a recorded price of $0.00 per share.
Does the FLEXSTEEL INDUSTRIES INC (FLXS) Form 4 show any insider stock sales?
The Form 4 does not show any insider stock sales. It reports only an acquisition of 544 common shares by director Michael Scott Culbreth through a grant classified as quarterly non-executive director compensation.
How is the FLEXSTEEL INDUSTRIES INC (FLXS) director stock grant described in the Form 4 footnotes?
The footnote explains that the 544 shares were awarded as part of quarterly non-executive director compensation. This clarifies that the transaction is a routine equity grant tied to board service rather than a discretionary market trade.